C-Reactive Protein Levels and Survival Following Cytoreductive Nephrectomy in 118 Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Study

BACKGROUND: This study aimed to evaluate the factors associated with a survival benefit for patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib, with and without cytoreductive nephrectomy (CN). MATERIAL/METHODS: This retrospective clinical study included 118 patients with mRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wen-Hao, Wang, Jun, Huo, Da-Zhu, Yin, Guo-Cai, Cao, Da-Long, Shi, Guo-Hai, Qu, Yuan-Yuan, Ye, Ding-Wei, Zhang, Hai-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897293/
https://www.ncbi.nlm.nih.gov/pubmed/31769434
http://dx.doi.org/10.12659/MSM.918635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897293/
https://www.ncbi.nlm.nih.gov/pubmed/31769434
http://dx.doi.org/10.12659/MSM.918635

Ejemplares similares